Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 41

Sort by

Sort Order Select

Journal Articles

Robust Hematopoietic Stem Cell Function and Minimal Myeloid Skewing with Aging in Un-Separated Murine Whole Bone Marrow: What Are We Losing with Hematopoietic Stem Cell Purification?

Mark S Dooner, Elaine Papa, Michael Del Tatto, Mandy Pereira, Sicheng Wen, MD PhD, Yan Cheng, PhD, Peter J. Quesenberry, MD, Laura R Goldberg, MD PhD

Blood (2019) 134 (Supplement_1): 3723.

https://doi.org/10.1182/blood-2019-124367

Published: 2019

Journal Articles

Dual-Switch CAR-T Cells: Orthogonal Molecular Switches to Control Activation and Elimination of CAR-T Cells to Target CD123 + Cancer

J. Henri Bayle, PhD, MyLinh T Duong, PhD, An Lu, Eva Morschl, PhD, Matthew R. Collinson-Pautz, PhD, Kelly L Sharp, Slawomir Szymanski, PhD, Mary E. Brandt, Kevin M. Slawin, MD, Steven Toler, PhD, Eric Yvon, S., Aaron Foster, David M. Spencer

Blood (2017) 130 (Supplement 1): 3184.

https://doi.org/10.1182/blood.V130.Suppl_1.3184.3184

Published: 2017

Journal Articles

Hematopoietic Stem Cell Potential within the Primary Sorted Lineage Positive Population: What Are We Losing with Hematopoietic Stem Cell Purification?

Laura R Goldberg, MD PhD, Mark S Dooner, Elaine Papa, Michael Del Tatto, Isabel Barnet, Mandy Pereira, Sicheng Wen, MD PhD, Yan Cheng, Peter J. Quesenberry, MD

Blood (2017) 130 (Supplement 1): 1145.

https://doi.org/10.1182/blood.V130.Suppl_1.1145.1145

Published: 2017

Journal Articles

Suicide in European Hodgkin Lymphoma Patients

Austin Kim, MD, Andreas Engert, MD, Helen Gorgen, Louise Maranda, PhD, Ann S LaCasce, MD, Sven Borchmann, MD

Blood (2016) 128 (22): 2995.

https://doi.org/10.1182/blood.V128.22.2995.2995

Published: 2016

Journal Articles

New Hyperactive Factor IX Variants Bioengineered Based upon Biochemical Studies of Factor IX Padua

Ben J. Samelson-Jones, MD PhD, Jonathan D Finn, PhD, Rodney M. Camire, PhD, Valder R Arruda, MD PhD

Blood (2016) 128 (22): 1384.

https://doi.org/10.1182/blood.V128.22.1384.1384

Published: 2016

Journal Articles

Gene Modification of Human Hematopoietic Stem Cells with Suicide Genes As a Safety Control

Laurel Christine Truscott, MD, Tzu Ting Chiou, PhD, Roy L. Kao, MD, Satiro N. De Oliveira, MD

Blood (2016) 128 (22): 5888.

https://doi.org/10.1182/blood.V128.22.5888.5888

Published: 2016

Journal Articles

Tracking Genetically Engineered Lymphocytes Long-Term Reveals the Dynamics of T-Cell Immunological Memory

Blood (2015) 126 (23): 263.

https://doi.org/10.1182/blood.V126.23.263.263

Published: 2015

Journal Articles

Human Induced Pluripotent Stem Cells Incorporating Safe Harbor Loci Integrated Inducible Suicide Systems for Use in the Application of Cellular Therapeutics

Xiaosong Huang, PhD, Weijie Lan, PhD, Philippe Parone, PhD, Raedun Clarke, PhD, Ramzey Abujarour, PhD, Megan Robinson, BS, Miguel Meza, MS, Sarah Raynel, MS, Betsy Rezner, BS, David Robbins, BS, Tom Tong Lee, PhD, Daniel Shoemaker, PhD, Bahram Valamehr, PhD MBA

Blood (2015) 126 (23): 3237.

https://doi.org/10.1182/blood.V126.23.3237.3237

Published: 2015

Journal Articles

T Cell Products of Defined CD4:CD8 Composition and Prescribed Levels of CD19CAR/Egfrt Transgene Expression Mediate Regression of Acute Lymphoblastic Leukemia in the Setting of Post-Allohsct Relapse

Rebecca A Gardner, MD, Julie R Park, MD, Karen S Kelly-Spratt, PhD, Olivia Finney, PhD, Hannah Smithers, Virginia Hoglund, Christopher Brown, Stephanie Mgebroff, MS, Catherine G. Lindgren, Assaf P Oron, PhD, Marie Bleakley, MD, Michael C Jensen, MD

Blood (2014) 124 (21): 3711.

https://doi.org/10.1182/blood.V124.21.3711.3711

Published: 2014

Journal Articles

GvHD Kinetics after Haploidentical TK-Cells: In-Vivo HSV-TK Suicide Machinery Is Effective in GvHD Control and Provide a Long-Term Immune-Suppressive Treatment-Free Survival

Maria Teresa Lupo-Stanghellini, MD, Chiara Bonini, MD, Giacomo Oliveira, MSc, Attilio Bondanza, MD PhD, Luca Vago, MD PhD, Raffaella Greco, MD, Jacopo Peccatori, MD, Scialini Colombi, BSc, Antonio Lambiase, MD, Fabio Ciceri, MD, Claudio Bordignon, MD

Blood (2014) 124 (21): 548.

https://doi.org/10.1182/blood.V124.21.548.548

Published: 2014

Journal Articles

Truncated Cell-Surface CD19 As a Conditional Suicide Switch For Adoptive T Cell Immunotherapy

Lihua Elizabeth Budde, MD, PhD, Armen Mardiros, MS, Wen-Chung Chang, MS, Xiuli Wang, MD, PhD, Carolina Berger, MD, Christine Brown, PhD, Stanley R Riddell, MD, Oliver W. Press, MD, PhD, Stephen J. Forman, MD

Blood (2013) 122 (21): 1660.

https://doi.org/10.1182/blood.V122.21.1660.1660

Published: 2013

Journal Articles

To Each His Own: Fever Induces Different Suicide Mechanisms in Early and Late Stage Plasmodium falciparum Malaria Parasites in vitro

Theresa L. Coetzer, PhD, Dewaldt Engelbrecht

Blood (2013) 122 (21): 3427.

https://doi.org/10.1182/blood.V122.21.3427.3427

Published: 2013

Journal Articles

Lymphodepletion Followed By Suicide-Gene-Transduced Donor Lymphocyte Infusion: A Strategy To Safely Enhance The Graft-Versus-Tumor Effect

Blood (2013) 122 (21): 153.

https://doi.org/10.1182/blood.V122.21.153.153

Published: 2013

Journal Articles

NETosis: how vital is it?

Bryan G. Yipp, Paul Kubes

Blood (2013) 122 (16): 2784–2794.

https://doi.org/10.1182/blood-2013-04-457671

Published: 2013

Journal Articles

Cycling Marrow Stem Cells Are Lost with Purification.

Laura R Goldberg, MD, PhD, Mark S Dooner, Mandy Pereira, Michael DelTatto, Elaine Papa, BS, Ashley Amaral, Jason M Aliotta, MD, Peter J Quesenberry, MD

Blood (2012) 120 (21): 2308.

https://doi.org/10.1182/blood.V120.21.2308.2308

Published: 2012

Journal Articles

In Vivo comparison of 3 Suicide Gene-Prodrug Combinations in a Mouse Graft-Versus-Host-Disease Model

Jae H. Park, MD, Raymond Yeh, PhD, Isabelle Riviere, PhD, Michel Sadelain, MD, PhD, Renier Brentjens, MD, PhD

Blood (2011) 118 (21): 3121.

https://doi.org/10.1182/blood.V118.21.3121.3121

Published: 2011

Journal Articles

Different Definitions of Progression-Free Survival (PFS) and Event-Free Survival (EFS) May Result In Perceived but Not Real Differences In Long-Term Outcome When Comparing Trials In Chronic Myeloid Leukemia (CML)

Hagop Kantarjian, MD, Susan O'Brien, MD, Elias Jabbour, MD, Jianqin Shan, PhD, Farhad Ravandi, MD, Tapan Kadia, MD, Jorge E. Cortes, MD, Stefan Faderl, MD, Guillermo Garcia-Manero, MD, Gautam Borthakur, MD

Blood (2010) 116 (21): 672.

https://doi.org/10.1182/blood.V116.21.672.672

Published: 2010

Journal Articles

Comparison of Dfferent Suicide Gene Strategies for the Safety Improvement of Genetically Manipulated T Cells.

Virna Marin, Post, Doc, Irene Pizzitola, PhD, student, Andrea Biondi, Professor, MD, Ettore Biagi, MD, Martin Pule

Blood (2010) 116 (21): 3753.

https://doi.org/10.1182/blood.V116.21.3753.3753

Published: 2010

Journal Articles

In Vitro analysis of Suicide Gene Expression and Function of 3 Suicide Gene-Prodrug Combinations In Human T Lymphocytes Further Modified to Express the CD19 Targeted 19–28z Chimeric Antigen Receptor.

Jae H. Park, MD, Raymond Yeh, PhD, Isabelle Rivière, PhD, Michel Sadelain, MD, PhD, Renier J. Brentjens, MD, PhD

Blood (2010) 116 (21): 3771.

https://doi.org/10.1182/blood.V116.21.3771.3771

Published: 2010

Journal Articles

A General Theory of Marrow Stem Cell Fate Determination

Peter J Quesenberry, MD, Mark S Dooner, Laura R Goldberg, MD, PhD

Blood (2010) 116 (21): 4794.

https://doi.org/10.1182/blood.V116.21.4794.4794

Published: 2010

NARROW

Robust Hematopoietic Stem Cell Function and Minimal Myeloid Skewing with Aging in Un-Separated Murine Whole Bone Marrow: What Are We Losing with Hematopoietic Stem Cell Purification?

Dual-Switch CAR-T Cells: Orthogonal Molecular Switches to Control Activation and Elimination of CAR-T Cells to Target CD123 + Cancer

Hematopoietic Stem Cell Potential within the Primary Sorted Lineage Positive Population: What Are We Losing with Hematopoietic Stem Cell Purification?

Suicide in European Hodgkin Lymphoma Patients

New Hyperactive Factor IX Variants Bioengineered Based upon Biochemical Studies of Factor IX Padua

Gene Modification of Human Hematopoietic Stem Cells with Suicide Genes As a Safety Control

Tracking Genetically Engineered Lymphocytes Long-Term Reveals the Dynamics of T-Cell Immunological Memory

Human Induced Pluripotent Stem Cells Incorporating Safe Harbor Loci Integrated Inducible Suicide Systems for Use in the Application of Cellular Therapeutics

T Cell Products of Defined CD4:CD8 Composition and Prescribed Levels of CD19CAR/Egfrt Transgene Expression Mediate Regression of Acute Lymphoblastic Leukemia in the Setting of Post-Allohsct Relapse

GvHD Kinetics after Haploidentical TK-Cells: In-Vivo HSV-TK Suicide Machinery Is Effective in GvHD Control and Provide a Long-Term Immune-Suppressive Treatment-Free Survival

Truncated Cell-Surface CD19 As a Conditional Suicide Switch For Adoptive T Cell Immunotherapy

To Each His Own: Fever Induces Different Suicide Mechanisms in Early and Late Stage Plasmodium falciparum Malaria Parasites in vitro

Lymphodepletion Followed By Suicide-Gene-Transduced Donor Lymphocyte Infusion: A Strategy To Safely Enhance The Graft-Versus-Tumor Effect

NETosis: how vital is it?

Cycling Marrow Stem Cells Are Lost with Purification.

In Vivo comparison of 3 Suicide Gene-Prodrug Combinations in a Mouse Graft-Versus-Host-Disease Model

Different Definitions of Progression-Free Survival (PFS) and Event-Free Survival (EFS) May Result In Perceived but Not Real Differences In Long-Term Outcome When Comparing Trials In Chronic Myeloid Leukemia (CML)

Comparison of Dfferent Suicide Gene Strategies for the Safety Improvement of Genetically Manipulated T Cells.

In Vitro analysis of Suicide Gene Expression and Function of 3 Suicide Gene-Prodrug Combinations In Human T Lymphocytes Further Modified to Express the CD19 Targeted 19–28z Chimeric Antigen Receptor.

A General Theory of Marrow Stem Cell Fate Determination

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only